Applied Therapeutics Inc (NASDAQ:APLT)
| 1.09 Delayed Data As of Feb 03 |  0.00 / 0.00%Today’s Change | 0.50 Today|||52-Week Range 3.03 | +43.42% Year-to-Date |
Latest APLT News | Press Releases
No recent news for Applied Therapeutics Inc.
Today’s Trading
| Previous close | 1.09 |
| Today’s open | 1.13 |
| Day’s range | 1.09 - 1.17 |
| Volume | 9,951 |
| Average volume (3 months) | 325,189 |
| Market cap | $52.4M |
Data as of 4:00pm ET, 02/03/2023
Growth & Valuation
| Earnings growth (last year) | +3.57% |
| Earnings growth (this year) | +43.37% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.46 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AXLAAxcella Health Inc | 0.00 | 0.00% |
| MGTAMagenta Therapeutics... | +0.30 | +52.58% |
| DYAIDyadic International... | 0.00 | 0.00% |
| ASLNAslan Pharmaceutical... | -0.01 | -0.94% |
Data as of 3:59pm ET, 02/03/2023
Financials
| Next reporting date | March 17, 2023 |
| EPS forecast (this quarter) | -$0.41 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$105.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
